Selective abrogation of FK-506 mediated anti-proliferative effects of IL-2 but not IL-7

MJ Rieder, WY Almawi, DA Hess, HH Kaidbey, DM Chudzik, JW Assi

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)162-162
Number of pages1
JournalClinical Pharmacology and Therapeutics
Volume59
Issue number2
Publication statusPublished - 1996

Cite this

Rieder, MJ., Almawi, WY., Hess, DA., Kaidbey, HH., Chudzik, DM., & Assi, JW. (1996). Selective abrogation of FK-506 mediated anti-proliferative effects of IL-2 but not IL-7. Clinical Pharmacology and Therapeutics, 59(2), 162-162.

Selective abrogation of FK-506 mediated anti-proliferative effects of IL-2 but not IL-7. / Rieder, MJ; Almawi, WY; Hess, DA; Kaidbey, HH; Chudzik, DM; Assi, JW.

In: Clinical Pharmacology and Therapeutics, Vol. 59, No. 2, 1996, p. 162-162.

Research output: Contribution to journalArticle

Rieder, MJ, Almawi, WY, Hess, DA, Kaidbey, HH, Chudzik, DM & Assi, JW 1996, 'Selective abrogation of FK-506 mediated anti-proliferative effects of IL-2 but not IL-7', Clinical Pharmacology and Therapeutics, vol. 59, no. 2, pp. 162-162.
Rieder MJ, Almawi WY, Hess DA, Kaidbey HH, Chudzik DM, Assi JW. Selective abrogation of FK-506 mediated anti-proliferative effects of IL-2 but not IL-7. Clinical Pharmacology and Therapeutics. 1996;59(2):162-162.
Rieder, MJ ; Almawi, WY ; Hess, DA ; Kaidbey, HH ; Chudzik, DM ; Assi, JW. / Selective abrogation of FK-506 mediated anti-proliferative effects of IL-2 but not IL-7. In: Clinical Pharmacology and Therapeutics. 1996 ; Vol. 59, No. 2. pp. 162-162.
@article{e0125c2e629e413b8d37fb3931373a8e,
title = "Selective abrogation of FK-506 mediated anti-proliferative effects of IL-2 but not IL-7",
author = "MJ Rieder and WY Almawi and DA Hess and HH Kaidbey and DM Chudzik and JW Assi",
year = "1996",
language = "English",
volume = "59",
pages = "162--162",
journal = "Clinical Pharmacology and Therapeutics",
issn = "0009-9236",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Selective abrogation of FK-506 mediated anti-proliferative effects of IL-2 but not IL-7

AU - Rieder, MJ

AU - Almawi, WY

AU - Hess, DA

AU - Kaidbey, HH

AU - Chudzik, DM

AU - Assi, JW

PY - 1996

Y1 - 1996

M3 - Article

VL - 59

SP - 162

EP - 162

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

SN - 0009-9236

IS - 2

ER -